◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Carna Biosciences,Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ3 2025Aug 07, 2025Q4 2024Dec 31, 2024Q3 2024Aug 08, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
+Operating Income -1.1B -- -863.7M -- -- --
Operating Margin % 100.7% -- 99.5% -- -- --
+Ordinary Income -1.1B -- -868.4M -- -- --
Revenue Growth % -- -- -- -- -- --
Line ItemQ3 2025Aug 07, 2025Q4 2024Dec 31, 2024Q3 2024Aug 08, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
Current Assets 2.7B -- 4.2B -- -- --
Total Assets 2.8B 3.9B 4.3B 4.9B 5.4B 4.2B
Current Liabilities 223.0M -- 375.9M -- -- --
Total Liabilities 296.8M 376.2M 472.4M 547.4M 814.5M 677.8M
Total Equity 2.5B 3.5B 3.9B 4.4B 4.5B 3.6B
Equity Ratio -- 0.90 -- 0.89 0.85 0.84
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...